IGI Logo

Morepen Laboratories is currently trading at Rs. 25.09, up by 0.20 points or 0.80% from its previous closing of Rs. 24.89 on the BSE.

The scrip opened at Rs. 24.70 and has touched a high and low of Rs. 25.39 and Rs. 24.70 respectively. So far 106283 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 54.80 on 26-Apr-2022 and a 52 week low of Rs. 23.65 on 28-Sep-2022.

Last one week high and low of the scrip stood at Rs. 26.50 and Rs. 24.11 respectively. The current market cap of the company is Rs. 1275.37 crore.

The promoters holding in the company stood at 38.22%, while Institutions and Non-Institutions held 4.63% and 57.14% respectively.

Morepen Laboratories has incorporated a Wholly Owned Subsidiary (WOS) in the name of ‘MOREPEN RX’. The company has incorporated a WOS on March 17, 2023.

The newly incorporated subsidiary has many objectives some of them are to carry on in India or abroad business of importers, merchants, general order suppliers, commission agents, representatives, distributors, royalty owner, contractors, auctioneers, indent agents, passage agents, factors, organizers, concessionaries, sale agents, sub agents; to establish and run health portal, web sites, medical transcription centers, data processing/computer centers, retail chains, ecommerce, and to offer wholesale, retail, ecommerce facilities, health constancy and data processing and other services that are normally offered by health portal, web sites, medical transcription centers, data processing/computer centers, retail chains, etc.

Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs, Home Diagnostics, Formulations and OTC products.